Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Royalty Pharma Dividend Announcement
• Royalty Pharma announced a quarterly dividend of $0.21 per ordinary share which will be made payable on 2024-12-10. Ex dividend date: 2024-11-15
• Royalty Pharma annual dividend for 2024 was $0.84
• Royalty Pharma annual dividend for 2023 was $0.80
• Royalty Pharma's trailing twelve-month (TTM) dividend yield is 3.15%
• Royalty Pharma's payout ratio for the trailing twelve months (TTM) is 32.50%
Royalty Pharma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-15 | $0.21 | quarterly | 2024-12-10 |
2024-08-16 | $0.21 | quarterly | 2024-09-13 |
2024-05-16 | $0.21 | quarterly | 2024-06-14 |
2024-02-15 | $0.21 | quarterly | 2024-03-15 |
2023-11-16 | $0.20 | quarterly | 2023-12-15 |
2023-08-17 | $0.20 | quarterly | 2023-09-15 |
2023-05-18 | $0.20 | quarterly | 2023-06-15 |
2023-02-15 | $0.20 | quarterly | 2023-03-15 |
2022-11-17 | $0.19 | quarterly | 2022-12-15 |
2022-08-18 | $0.19 | quarterly | 2022-09-15 |
2022-05-19 | $0.19 | quarterly | 2022-06-15 |
2022-02-17 | $0.19 | quarterly | 2022-03-15 |
2021-11-18 | $0.17 | quarterly | 2021-12-15 |
2021-08-19 | $0.17 | quarterly | 2021-09-15 |
2021-05-19 | $0.17 | quarterly | 2021-06-15 |
2021-02-18 | $0.17 | quarterly | 2021-03-15 |
2020-11-19 | $0.15 | quarterly | 2020-12-15 |
2020-09-14 | $0.15 | quarterly | 2020-09-30 |
Royalty Pharma Dividend per year
Royalty Pharma Dividend growth
Royalty Pharma Dividend Yield
Royalty Pharma current trailing twelve-month (TTM) dividend yield is 3.15%. Interested in purchasing Royalty Pharma stock? Use our calculator to estimate your expected dividend yield:
Royalty Pharma Financial Ratios
Royalty Pharma Dividend FAQ
Other factors to consider when evaluating Royalty Pharma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Royalty Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Royalty Pharma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Royalty Pharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Royalty Pharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Royalty Pharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Royalty Pharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Royalty Pharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Royalty Pharma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Royalty Pharma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Royalty Pharma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.